Daniel R S Habib, Matthew Shou, James L Rogers, Kevin Sun, Chen Chia Wang, Aimal Khan
{"title":"少即是多:早期结直肠癌过度治疗的危险因素和生存结果。","authors":"Daniel R S Habib, Matthew Shou, James L Rogers, Kevin Sun, Chen Chia Wang, Aimal Khan","doi":"10.1002/jso.70028","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>After cT1-2N0M0 colorectal cancer (CRC) definitive resection (colectomy/proctectomy) without pathologic upstaging, only observation is recommended given the lack of benefit from adjuvant treatment, which would constitute overtreatment. This study aims to determine risk factors and overall survival (OS) associated with overtreatment in early-stage CRC.</p><p><strong>Methods: </strong>This National Cancer Database study included cT1-T2N0M0 CRC patients who underwent definitive resection between 2010 and 2020. Multivariable logistic regressions were performed to assess overtreatment risk factors. After propensity-matching, Kaplan-Meier survival analyses and multivariable Cox proportional-hazards analyses were performed to assess the association of overtreatment with OS.</p><p><strong>Results: </strong>Of 22 875 colon cancer and 4198 rectal cancer cases, 144 (0.6%) and 82 (2.0%) were overtreated, respectively. Colon cancer overtreatment was associated with younger age (aOR = 0.96, 95% CI = 0.95-0.98), Black race (aOR = 1.94, 95% CI = 1.26-2.99), and pT2 vs. pT1 (aOR = 1.66, 95% CI = 1.19-2.33). Rectal cancer overtreatment was associated with pT2 (aOR = 2.58, 95% CI = 1.59-4.19), poor/undifferentiated grade (aOR = 2.61, 95% CI = 1.44-4.76), and high-risk histology (aOR = 3.20, 95% CI = 1.22-8.40). In the propensity-matched cohorts, overtreatment was associated with worse OS for colon (HR = 1.40, 95% CI = 1.01-1.93) but not rectal cancer (HR = 1.05, 95% CI = 0.66-1.68).</p><p><strong>Conclusions: </strong>Patient and tumor characteristics predicted early-stage CRC overtreatment. Overtreatment was associated with worse OS for colon but not rectal cancer.</p>","PeriodicalId":17111,"journal":{"name":"Journal of Surgical Oncology","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Less Is More: Risk Factors and Survival Outcomes of Overtreatment for Early-Stage Colorectal Cancer.\",\"authors\":\"Daniel R S Habib, Matthew Shou, James L Rogers, Kevin Sun, Chen Chia Wang, Aimal Khan\",\"doi\":\"10.1002/jso.70028\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>After cT1-2N0M0 colorectal cancer (CRC) definitive resection (colectomy/proctectomy) without pathologic upstaging, only observation is recommended given the lack of benefit from adjuvant treatment, which would constitute overtreatment. This study aims to determine risk factors and overall survival (OS) associated with overtreatment in early-stage CRC.</p><p><strong>Methods: </strong>This National Cancer Database study included cT1-T2N0M0 CRC patients who underwent definitive resection between 2010 and 2020. Multivariable logistic regressions were performed to assess overtreatment risk factors. After propensity-matching, Kaplan-Meier survival analyses and multivariable Cox proportional-hazards analyses were performed to assess the association of overtreatment with OS.</p><p><strong>Results: </strong>Of 22 875 colon cancer and 4198 rectal cancer cases, 144 (0.6%) and 82 (2.0%) were overtreated, respectively. Colon cancer overtreatment was associated with younger age (aOR = 0.96, 95% CI = 0.95-0.98), Black race (aOR = 1.94, 95% CI = 1.26-2.99), and pT2 vs. pT1 (aOR = 1.66, 95% CI = 1.19-2.33). Rectal cancer overtreatment was associated with pT2 (aOR = 2.58, 95% CI = 1.59-4.19), poor/undifferentiated grade (aOR = 2.61, 95% CI = 1.44-4.76), and high-risk histology (aOR = 3.20, 95% CI = 1.22-8.40). In the propensity-matched cohorts, overtreatment was associated with worse OS for colon (HR = 1.40, 95% CI = 1.01-1.93) but not rectal cancer (HR = 1.05, 95% CI = 0.66-1.68).</p><p><strong>Conclusions: </strong>Patient and tumor characteristics predicted early-stage CRC overtreatment. Overtreatment was associated with worse OS for colon but not rectal cancer.</p>\",\"PeriodicalId\":17111,\"journal\":{\"name\":\"Journal of Surgical Oncology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Surgical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/jso.70028\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jso.70028","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景与目的:cT1-2N0M0型结直肠癌(CRC)最终切除(结肠切除术/直肠切除术)后,无病理上分期,由于缺乏辅助治疗的益处,建议仅观察,这将构成过度治疗。本研究旨在确定早期结直肠癌过度治疗相关的危险因素和总生存期(OS)。方法:这项国家癌症数据库研究纳入了2010年至2020年间接受最终切除术的cT1-T2N0M0结直肠癌患者。采用多变量logistic回归评估过度治疗的危险因素。在倾向匹配后,进行Kaplan-Meier生存分析和多变量Cox比例风险分析,以评估过度治疗与OS的关系。结果:22 875例结肠癌和4198例直肠癌患者中,过度治疗144例(0.6%)和82例(2.0%)。结肠癌过度治疗与年龄较小(aOR = 0.96, 95% CI = 0.95-0.98)、黑人(aOR = 1.94, 95% CI = 1.26-2.99)、pT2 vs pT1 (aOR = 1.66, 95% CI = 1.19-2.33)相关。直肠癌过度治疗与pT2 (aOR = 2.58, 95% CI = 1.59-4.19)、不良/未分化分级(aOR = 2.61, 95% CI = 1.44-4.76)和高危组织学(aOR = 3.20, 95% CI = 1.22-8.40)相关。在倾向匹配的队列中,过度治疗与较差的结肠癌OS相关(HR = 1.40, 95% CI = 1.01-1.93),但与直肠癌OS无关(HR = 1.05, 95% CI = 0.66-1.68)。结论:患者和肿瘤特征预测早期结直肠癌的过度治疗。过度治疗与结肠癌的OS恶化有关,但与直肠癌无关。
Less Is More: Risk Factors and Survival Outcomes of Overtreatment for Early-Stage Colorectal Cancer.
Background and objectives: After cT1-2N0M0 colorectal cancer (CRC) definitive resection (colectomy/proctectomy) without pathologic upstaging, only observation is recommended given the lack of benefit from adjuvant treatment, which would constitute overtreatment. This study aims to determine risk factors and overall survival (OS) associated with overtreatment in early-stage CRC.
Methods: This National Cancer Database study included cT1-T2N0M0 CRC patients who underwent definitive resection between 2010 and 2020. Multivariable logistic regressions were performed to assess overtreatment risk factors. After propensity-matching, Kaplan-Meier survival analyses and multivariable Cox proportional-hazards analyses were performed to assess the association of overtreatment with OS.
Results: Of 22 875 colon cancer and 4198 rectal cancer cases, 144 (0.6%) and 82 (2.0%) were overtreated, respectively. Colon cancer overtreatment was associated with younger age (aOR = 0.96, 95% CI = 0.95-0.98), Black race (aOR = 1.94, 95% CI = 1.26-2.99), and pT2 vs. pT1 (aOR = 1.66, 95% CI = 1.19-2.33). Rectal cancer overtreatment was associated with pT2 (aOR = 2.58, 95% CI = 1.59-4.19), poor/undifferentiated grade (aOR = 2.61, 95% CI = 1.44-4.76), and high-risk histology (aOR = 3.20, 95% CI = 1.22-8.40). In the propensity-matched cohorts, overtreatment was associated with worse OS for colon (HR = 1.40, 95% CI = 1.01-1.93) but not rectal cancer (HR = 1.05, 95% CI = 0.66-1.68).
Conclusions: Patient and tumor characteristics predicted early-stage CRC overtreatment. Overtreatment was associated with worse OS for colon but not rectal cancer.
期刊介绍:
The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.